2nd Bellwether Case Over Merck's Fosamax Nixed
A federal judge has dismissed the second bellwether case over Merck & Co. Inc.'s osteoporosis drug Fosamax, finding that the plaintiff's expert witnesses could not establish that the drug caused her...To view the full article, register now.
Already a subscriber? Click here to view full article